Lipid peroxidation is a common event even in health, and greatly accelerated in proinflammatory settings such as hypercholesterolemia. Consequently, oxidation-specific epitopes are generated, which are proinflammatory and immunogenic, leading to both adaptive and innate responses. Because innate immune mechanisms utilize conserved, germline pattern recognition receptors (PRRs) that are preformed and present at birth, it is not obvious why they should bind to such epitopes. In this review, we put forward the hypothesis that because oxidation-specific epitopes are ubiquitous in both health and disease, and because they in essence represent "danger signals," they constitute a class of pathogen associated molecular patterns (PAMPs), leading to the natural selection of multiple innate PRRs that target such epitopes. We suggest that apoptotic cells, and the blebs and microparticles released from such cells, all of which are rich in oxidation-specific epitopes and proinflammatory, constitute an endogenous set of selecting antigens. In turn, natural antibodies, scavenger receptors and soluble innate proteins, such as pentraxins, all represent PRRs that target such epitopes. We discuss the evidence for this hypothesis and the consequences of such responses in health and disease, such as atherosclerosis.
Introduction
Hypercholesterolemia not only leads to enhanced binding of apoB containing lipoproteins in the arterial intima, but also initiates the proinflammatory and pro-oxidant conditions that play an obligatory role in the perpetuation and progression of the disease. Inflammation is mediated by immune mechanisms, which profoundly impact atherogenesis, accelerating but providing atheroprotective influences as well, (1) (2) (3) (4) . Why should immune mechanisms be involved in the response to hypercholesterolemia? Immunity is most often thought of in the context of responses to infectious pathogens, but evidence to support other than a minor role for direct involvement of bacterial or viral agents in atherosclerosis is lacking. Indeed, atherogenesis can proceed in mice maintained even in a completely sterile environment (5) . In this review, we will develop the hypothesis that the enhanced lipid peroxidation that occurs with hypercholesterolemia, and the consequent generation of "oxidation-specific" epitopes, leads to activation of immune responses that impact atherogenesis. Understanding these mechanism will lead to new insights into atherogenesis, and may lead to novel immunoregulatory therapies to modulate disease progression.
Adaptive Immunity and Oxidation-Specific Epitopes
Adaptive immunity is the active response to perceived changes that are outside the realm of "self", such as the wide variety of epitopes presented by foreign pathogens. Indeed, the essence of adaptive immunity is the generation of an almost limitless number of high affinity B cell and T cell receptors (~10 14 to 10 18 ) through somatic mutations and induced junctional diversity at VDJ-gene recombination sites to produce both cellular (via T cells) as well as humoral immunity (via secreted antibodies (Ab) from B cell derived plasma cells) against selecting pathogens. Although the adaptive response is delayed in time due to the selection and maturation of T and B cell responses, it provides a specific and high-affinity response to newly recognized pathogens.
A variety of potential antigens have been described in the atherosclerotic lesion that could serve to activate such adaptive immune responses, including bacterial and viral antigens . However, among these, "oxidation-specific" epitopes, as occur when LDL is oxidized (OxLDL), are the ones most widely studied to date (4) . Multiple oxidative mechanisms are present in the vascular wall that can lead to the generation of highly reactive oxidized lipids . In turn, these can modify proteins and lipids present not only on LDL for example, but on a wide variety of extracellular and cellular components as well. We have termed these "oxidation-specific" epitopes to indicate that common modifications could be produced under widely different inflammatory settings, and on widely different proteins or even lipids. For example, the common oxidation products, malondialdehyde (MDA-and its many complex condensation products) can modify proteins and lipids leading to common "oxidation-specific" neo-epitopes that are immunogenic and importantly, are recognized in a hapten-specific manner. Thus, as we have shown, an MDA adduct formed on apoB of OxLDL could lead to hapten-specific MDA monoclonal antibodies (such as MDA2 and E014 (6;7)) that not only recognize MDA epitopes in atherosclerotic plaques (8) , but MDA modified proteins in diabetic kidneys (9) and Heyman nephritis (10); as well as in Alzheimer plaques (11) . Because lipid peroxidation is a common process even in health, and is greatly accelerated in inflammatory diseases, such oxidation-specific epitopes are ubiquitous in both health and disease. Indeed, cells undergoing apoptosis, which are under intense pro-oxidant stress, display a variety of immunogenic oxidation-specific epitopes on their surface (as discussed below) (12) . In turn, these "neo-self" epitopes are recognized as "foreign" by adaptive immune surveillance. Evidence for humoral and cell mediated immunity to a variety of oxidation-specific epitopes, such as autoantibodies to OxLDL and MDAmodified LDL (MDA-LDL), has been documented in both animal models of atherosclerosis and in humans (4;13 found in lesions, are nevertheless now thought to provide an overall protective function, in at least part through generation of Abs that bind to oxidation-specific epitopes (4).
Innate Immunity and Oxidation-Specific Epitopes
In contrast to adaptive responses, innate immunity utilizes natural selection of receptors, which provide a vital and non-redundant role in the initial defense against invading pathogens and in maintaining homeostasis against a variety of "self-antigens". Because these receptors are preformed and present at birth and/or matured via positive selection during the neonatal period or shortly thereafter, they are available for almost immediate defense against a perceived pathogen. Thus, innate receptors of necessity are focused on highly conserved motifs that are present on multiple pathogens, as well as many neo-epitopes and even apparent "self-or neo-self epitopes" These receptors are termed "pattern recognition receptors" (PRRs) and the "conserved" patterns to which they bind are termed "pathogen associated molecular patterns" (PAMPs).
In this review, we suggest that oxidation-specific epitopes are a major target of many innate PRRs.
However, it is not apparent why such preformed PRRs should be involved in a disease process such as atherosclerosis, which would not be expected to exert evolutionary pressure. We put forward the hypothesis that because oxidation-specific epitopes are ubiquitous in both health and disease, and because they in essence represent "danger signals," they constitute a class of PAMPs, that has led to the natural selection of multiple PRRs that target such epitopes. This includes both cellular PPRs, such as scavenger receptors (SRs) and toll-like receptors (TLRs) on macrophages, and soluble PPRs, such as pentraxins and
NAbs. Furthermore, the fact that oxidation-specific epitopes often-if not frequently-share molecular identity with epitopes found on infectious pathogens as well, provides further selecting pressure for receptors targeted to such epitopes. Thus, oxidation-specific epitopes are a major target of innate immunity.
Natural Antibodies recognize oxidation-specific epitopes
Our own appreciation that NAbs recognized oxidation-specific epitopes arose from studies in which we cloned a panel of hybridomas from cholesterol-fed apoE-deficient mice, which have high IgM titers to such epitopes. We cloned eight hybridomas secreting IgM to OxLDL (7) . Each of these, such as the prototypic E06, bound to both the lipid and apoB moiety of OxLDL, and specifically, to the phosphocholine (PC) headgroup of oxidized phospholipids (OxPL), (such as POVPC (1-palmitoyl-2-(5'-oxovaleroyl)-sn-glycero-3-phosphocholine)), but not to the PC of native PL (17) (18) (19) . In the case of the apoB isolated from OxLDL, we showed that the OxPL was covalently linked to the lysines of apoB via the reactive aldehydes of the oxidized sn2 side chain, leaving the PC headgroup free to bind E06.
E06 became of enormous interest when we found that it inhibited the uptake of OxLDL by macrophage scavenger receptors CD36 and SR-BI (20;21) . Indeed, we demonstrated that both the lipid moiety of OxLDL, as well as the solubilized apoB of OxLDL, could bind to CD36 and that E06 could inhibit the binding of both. Further, we showed that POVPC linked to BSA via its sn2 side chain also blocked the binding of OxLDL. These data strongly supported the interpretation that the PC moiety of thus, the IgM they generate are reflective of germline usage, with minimal to no mutations (25) . Because they are conserved by natural selection, the presumption is that fundamentally, NAbs provide advantageous properties maintaining homeostasis, such as their crucial role in immediate host defenses against "pathogens"(26), which, as we show below, include endogenous pathogens bearing "neo-self" epitopes, such as oxidation-specific epitopes.
We subsequently showed, by direct sequencing of the V H /V L chains and use of anti-idiotypic Abs, that all the hybridomas were 100% homologous to the classic germline encoded NAb T15, secreted by a well-characterized B-1 cell clone described over 30 years ago (18) . The T15 clone, which was a spontaneous murine plasmacytoma that secreted an IgA with the T15 idiotype, is considered the classic germline NAb. It was intensively studied because it binds to PC (not as part of a PL) covalently linked to the cell-wall polysaccharide (C-PS) of pathogens and confers optimal protection to mice from lethal infection with S. pneumonia (27) . In further studies cited below, we went on to show that such OxPL were greatly increased in apoptotic cells as well (28) . Thus, these studies demonstrated molecular (and immunological) mimicry between the PC of OxPL present on OxLDL and apoptotic cells on one hand, and the PC moiety present on pneumococcus and many other infections pathogens on the other hand.
This dual specificity for an endogenous "self-or neo-self-" antigen, and an exogenous pathogen has been described as a characteristic of NAbs (26) . 
Macrophage PRRs recognize oxidation-specific epitopes:
"Scavenger receptors" of macrophages were so named because they bound and internalized
OxLDL, but not native LDL (35) (38) . However, it is now apparent that a variety of SR recognize various oxidation-specific epitopes present on OxLDL, and on apoptotic cells, including SRA-1,2 MARCOS, CD36, SR-BI, LOX-1, PSOX and others (36) .
Furthermore, evidence is beginning to accumulate that another important class of innate PRRs, members of the TLR family and associated proteins, such as MD2, also bind mmLDL and OxLDL, and certain oxidized phospholipids, fatty acids and cholesteryl esters, perhaps in cooperation with some of the SRs noted above (39) (40) (41) .
The exact chemical structures of the oxidation-specific epitopes to which they bind are beginning to be defined. Work from our laboratory first showed that the same PC containing OxPL on OxLDL and apoptotic cells recognized by NAb E06 was also a specific ligand recognized by CD36 and SR-B1 to SR-A, but at different molecular sites (44) . Because these PRRs are germline encoded, and thus limited in number, it is likely that those receptors with the capacity to bind multiple ligands, perhaps even related epitopes, such as oxidation-specific epitopes, would be the ones most conserved.
Soluble PRRs recognize oxidation-specific epitopes
Aside from NAbs, among the known soluble innate proteins, the only one which to date has been shown to bind to an oxidation epitope is the short pentraxin C-Reactive Protein (CRP). CRP is an acute phase protein and a valuable biomarker of the inflammatory state, has became widely known now as an important and independent biomarker of cardiovascular disease. However, this protein was originally noted for its ability to bind to the PC adduct covalently bound to the C-PS of S. pneumonia and for its ability to mediate enhanced clearance of this and other pathogens. However, we have shown that similar to E06, CRP specifically binds to the PC moiety of oxidized phospholipids (OxPL), whether present on OxLDL or on apoptotic cells, but does not bind to the PC of unoxidized phospholipids (45) . Furthermore, CRP is found in atherosclerotic lesions and is colocalized with PC containing OxPL, presumably on
OxLDL and apoptotic cells (45) . Indeed, CRP binds to ischemic myocardium in experimentally induced myocardial infarction (46), and we speculate that the CRP binds directly to the apoptotic and dying cells expressing such oxidized phospholipids.
There are a variety of other soluble innate proteins, including other pentraxins and various complement proteins, and we hypothesize that future studies will find that many other highly conserved "innate" soluble proteins will be identified with the capacity to bind such epitopes.
Summary and functional roles of innate PRRs to oxidation-specific epitopes
Our general hypothesis that oxidation-specific epitopes are an important target of innate immunity, and form a novel set of PAMPs that are recognized by multiple PRRs of innate immunity is summarized in the Figure. In the case of PC as a PAMP, published data strongly support this paradigm. Thus, the PC of unoxidized PL, as present in native LDL or viable cells, is "self" and not recognized by innate PRRs.
In contrast, the PC of OxPL, present on OxLDL and on apoptotic cells, becomes "altered self" and is recognized by specific NAbs, such as E06; by scavenger receptors, such as CD36 and SR-B1; and by innate soluble proteins, such as CRP. In turn, we suggest that each of these PRR will also recognize the PC present on the cell wall polysaccharide of pathogens, such as S. pneumoniae.
In a similar manner, there is published and developing data that MDA, (and its inclusive set of adducts) is another equally important class of PAMPs. We predict that in a similar manner other oxidation-specific epitopes, such as MDA, 4-HNE and OxCL, will be PAMPs for a concerted set of innate PRRs. Likely, other types of common post-transcriptional modifications, such as advanced glycation endpoducts, will similarly be found to be targets of these innate PRRs.
Because PRR are germline encoded, the observation that oxidation-specific epitopes, such as PC, are targeted by multiple innate PRRs strongly implies that these epitopes represent important "danger signals" against which multiple defenses are selected to provide homeostasis. Although many of these NAbs also bind infectious pathogens, because B-1 cells are positively selected in fetal life, or shortly thereafter, and because NAbs are present even in germfree mice, this strongly implies that endogenous antigens must be the primary selecting antigens. A similar argument may be offered for scavenger receptors, and even some innate soluble proteins. However, the observation that these PRRs also recognize similar epitopes on infectious pathogens suggests that they are likely to be important activating agents later in life as well.
We also suggest that the fundamentally important "altered-self" antigens leading to oxidation- There are other potential protective mechanisms for NAbs that can be proposed. As noted above, 
Therapeutic applications:
Because NAbs have been conserved by natural selection, it is likely that on balance they must have beneficial to the host. Because we have shown in principle that increasing the titer of such antibodies can be antiatherogenic, identifying the epitopes to which such NAbs bind should identify antigens that could be used to develop an atheroprotective vaccine. In addition, enhancing such NAb titers, possibly even passively, could be used to limit the proinflammatory effects of oxidized lipids in acute situations, such as in acute coronary syndromes (49), or in viral induced respiratory distress syndromes (32) . Antibodies to these epitopes could be used to image not only atherosclerotic lesions (50), but a variety of inflammatory settings in which such epitopes are expressed, as well as to target therapeutic molecules to active sites of inflammation. It can be envisioned that a better understanding of this important compartment of innate immunity will ultimately identify novel therapeutic targets that can be exploited to interfere with atherogenesis and inflammatory states in general. 
Figure Legend
Oxidation-specific epitopes are a class of PAMPs recognized by multiple arcs of innate immunity, including Natural Antibodies, Scavenger receptors, and Innate Soluble Proteins. These epitopes may be derived from oxidation-induced alterations of "self" to generate "altered self," which become "danger signals" targeted by multiple arcs of innate immunity. In addition, these epitopes often share molecular identity with structures on infectious pathogens. (Modified from Figure 1 Oxidation-specific epitopes
